- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Anonymous complaint alleged sales reps used an “Oncology Product Pipeline Update” to promote unlicensed products. Panel found reps…
Ex-employee alleged portfolio “bundling” created an incentive to prescribe Botox. PMCPA found the arrangements were terms of trade…
Anonymous pharmacist alleged an Apo-go nurse advisor changed Parkinson’s medicines without authority and failed to inform PDNSs. Panel…
Anonymous complaint about a Novo Nordisk symposium invitation email. Most allegations were not upheld, but the opt-in wording…
GSK admitted two Benlysta promotional case studies were emailed to 48 HCPs before certification. Emails lacked integral prescribing…
ESMO booth materials for Navelbine were in scope of the UK Code. “Rare cumulative toxicity” and “easily manageable…
Merck Serono’s UK press release on FIRE-3 claimed Erbitux extended survival by 7.5 months. PMCPA found the headline,…
Anonymous complaint alleged off-label promotion of COPD inhalers for exacerbation reduction. Panel found some materials acceptable in context,…
A hospital consultant received a Qtern promotional email via a third-party network without valid prior permission. The Panel…
A consultant complained about unsolicited Grazax emails. PMCPA found no explicit opt-in for promotional email and that launch-period…
One real case. One key lesson. Every week — free.